Shanghai Shen Lian Biomedical Corp (688098) — Cash Flow Quality Index
Shanghai Shen Lian Biomedical Corp (688098) has a Cash Flow Quality Index of 1.64x as of September 2025. Operating cash flow of CN¥21.52 Million exceeds net income of CN¥13.15 Million, indicating high earnings quality where cash backs reported profits. Explore how efficiently does Shanghai Shen Lian Biomedical Corp generate cash to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shanghai Shen Lian Biomedical Corp Cash Flow Quality Index (2013–2023)
Historical Cash Flow Quality Index for Shanghai Shen Lian Biomedical Corp across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Shanghai Shen Lian Biomedical Corp cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Shanghai Shen Lian Biomedical Corp (2013–2023)
Year-by-year earnings quality comparison for Shanghai Shen Lian Biomedical Corp. For live market cap and the full company financial profile, see Shanghai Shen Lian Biomedical Corp stock valuation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.12x | CN¥3.53 Million | CN¥29.85 Million | ▼ -20.8% |
| 2022 | 0.15x | CN¥9.09 Million | CN¥60.97 Million | ▼ -82.7% |
| 2021 | 0.86x | CN¥90.12 Million | CN¥104.46 Million | ▼ -0.1% |
| 2020 | 0.86x | CN¥111.73 Million | CN¥129.37 Million | ▲ +25.1% |
| 2019 | 0.69x | CN¥53.81 Million | CN¥77.96 Million | ▼ -50.1% |
| 2018 | 1.38x | CN¥121.13 Million | CN¥87.58 Million | ▲ +82.9% |
| 2017 | 0.76x | CN¥74.61 Million | CN¥98.68 Million | ▲ +15.7% |
| 2016 | 0.65x | CN¥48.00 Million | CN¥73.47 Million | ▲ +60.5% |
| 2015 | 0.41x | CN¥30.86 Million | CN¥75.84 Million | ▼ -76.5% |
| 2014 | 1.73x | CN¥105.98 Million | CN¥61.14 Million | ▲ +40.0% |
| 2013 | 1.24x | CN¥51.79 Million | CN¥41.82 Million | — |